Breast cancer has become a symbol of tremendous concern in the modern world, as it is one of the major causes of cancer mortality worldwide. In this concern, many people are frequently screening for breast cancer in order to be identified early and avert mortality from the disease by receiving treatment. Breast Ultrasonography Images are frequently utilized by doctors to diagnose breast cancer at an early stage. However, the complex artifacts and heavily noised Breast Ultrasonography Images make detecting Breast Cancer a tough challenge. Furthermore, the ever-increasing number of patients being screened for Breast Cancer necessitates the use of automated Computer Aided Technology for high accuracy diagnosis at a cheap cost and in a short period of time. The current progress of Artificial Intelligence (AI) in the fields of Medical Image Analysis and Health Care is a boon to humanity. In this study, we have proposed a compact integrated automated pipelining framework which integrates ultrasonography image preprocessing with Simple Linear Iterative Clustering (SLIC) to tackle the complex artifact of Breast Ultrasonography Images complementing semantic segmentation with Modified U-Net leading to Breast Tumor classification with robust feature extraction using a transfer learning approach with pretrained VGG 16 model and densely connected neural network architecture. The proposed automated pipeline can be effectively implemented to assist medical practitioners in making more accurate and timely diagnoses of breast cancer.
Quantitative assessment of Tumor-TIL spatial relationships is increasingly important in both basic science and clinical aspects of breast cancer research. We have developed and evaluated convolutional neural network (CNN) analysis pipelines to generate combined maps of cancer regions and tumor infiltrating lymphocytes (TILs) in routine diagnostic breast cancer whole slide tissue images (WSIs). We produce interactive whole slide maps that provide 1) insight about the structural patterns and spatial distribution of lymphocytic infiltrates and 2) facilitate improved quantification of TILs. We evaluated both tumor and TIL analyses using three CNN networks - Resnet-34, VGG16 and Inception v4, and demonstrated that the results compared favorably to those obtained by what believe are the best published methods. We have produced open-source tools and generated a public dataset consisting of tumor/TIL maps for 1,015 TCGA breast cancer images. We also present a customized web-based interface that enables easy visualization and interactive exploration of high-resolution combined Tumor-TIL maps for 1,015TCGA invasive breast cancer cases that can be downloaded for further downstream analyses.
We study the fully convolutional neural networks in the context of malignancy detection for breast cancer screening. We work on a supervised segmentation task looking for an acceptable compromise between the precision of the network and the computational complexity.
Empirical evaluation of breast tissue biopsies for mitotic nuclei detection is considered an important prognostic biomarker in tumor grading and cancer progression. However, automated mitotic nuclei detection poses several challenges because of the unavailability of pixel-level annotations, different morphological configurations of mitotic nuclei, their sparse representation, and close resemblance with non-mitotic nuclei. These challenges undermine the precision of the automated detection model and thus make detection difficult in a single phase. This work proposes an end-to-end detection system for mitotic nuclei identification in breast cancer histopathological images. Deep object detection-based Mask R-CNN is adapted for mitotic nuclei detection that initially selects the candidate mitotic region with maximum recall. However, in the second phase, these candidate regions are refined by multi-object loss function to improve the precision. The performance of the proposed detection model shows improved discrimination ability (F-score of 0.86) for mitotic nuclei with significant precision (0.86) as compared to the two-stage detection models (F-score of 0.701) on TUPAC16 dataset. Promising results suggest that the deep object detection-based model has the potential to learn the characteristic features of mitotic nuclei from weakly annotated data and suggests that it can be adapted for the identification of other nuclear bodies in histopathological images.
Structural and mechanical differences between cancerous and healthy tissue give rise to variations in macroscopic properties such as visual appearance and elastic modulus that show promise as signatures for early cancer detection. Atomic force microscopy (AFM) has been used to measure significant differences in stiffness between cancerous and healthy cells owing to its high force sensitivity and spatial resolution, however due to absorption and scattering of light, it is often challenging to accurately locate where AFM measurements have been made on a bulk tissue sample. In this paper we describe an image registration method that localizes AFM elastic stiffness measurements with high-resolution images of haematoxylin and eosin (H\&E)-stained tissue to within 1.5 microns. Color RGB images are segmented into three structure types (lumen, cells and stroma) by a neural network classifier trained on ground-truth pixel data obtained through k-means clustering in HSV color space. Using the localized stiffness maps and corresponding structural information, a whole-sample stiffness map is generated with a region matching and interpolation algorithm that associates similar structures with measured stiffness values. We present results showing significant differences in stiffness between healthy and cancerous liver tissue and discuss potential applications of this technique.
In this study I compare different architectures of convolutional neural networks and different hardware acceleration devices for the detection of breast cancer metastasis tissue from microscopic images of sentinel lymph nodes. Convolutional models with increasing depth are trained and tested on a public data set of more than 300,000 images of lymph node tissue, on three different hardware acceleration cards, using an off-the-shelf deep learning framework. The impact of transfer learning, data augmentation and hyperparameters fine-tuning are also tested. Hardware acceleration device performance can improve training time by a factor of five to seven, depending on the model used. On the other hand, increasing convolutional depth will augment the training time by a factor of four to six times, depending on the acceleration device used. Increasing the depth of the model, as could be expected, clearly improves performance, while data augmentation and transfer learning do not. Fine-tuning the hyperparameters of the model notably improves the results, with the best model showing a performance comparable to state-of-the-art models.
We hypothesize that probabilistic voxel-level classification of anatomy and malignancy in prostate MRI, although typically posed as near-identical segmentation tasks via U-Nets, require different loss functions for optimal performance due to inherent differences in their clinical objectives. We investigate distribution, region and boundary-based loss functions for both tasks across 200 patient exams from the publicly-available ProstateX dataset. For evaluation, we conduct a thorough comparative analysis of model predictions and calibration, measured with respect to multi-class volume segmentation of the prostate anatomy (whole-gland, transitional zone, peripheral zone), as well as, patient-level diagnosis and lesion-level detection of clinically significant prostate cancer. Notably, we find that distribution-based loss functions (in particular, focal loss) are well-suited for diagnostic or panoptic segmentation tasks such as lesion detection, primarily due to their implicit property of inducing better calibration. Meanwhile, (with the exception of focal loss) both distribution and region/boundary-based loss functions perform equally well for anatomical or semantic segmentation tasks, such as quantification of organ shape, size and boundaries.
In this paper, we studied extensively on different deep learning based methods to detect melanoma and skin lesion cancers. Melanoma, a form of malignant skin cancer is very threatening to health. Proper diagnosis of melanoma at an earlier stage is crucial for the success rate of complete cure. Dermoscopic images with Benign and malignant forms of skin cancer can be analyzed by computer vision system to streamline the process of skin cancer detection. In this study, we experimented with various neural networks which employ recent deep learning based models like PNASNet-5-Large, InceptionResNetV2, SENet154, InceptionV4. Dermoscopic images are properly processed and augmented before feeding them into the network. We tested our methods on International Skin Imaging Collaboration (ISIC) 2018 challenge dataset. Our system has achieved best validation score of 0.76 for PNASNet-5-Large model. Further improvement and optimization of the proposed methods with a bigger training dataset and carefully chosen hyper-parameter could improve the performances. The code available for download at https://github.com/miltonbd/ISIC_2018_classification
The early detection of cancer is a challenging problem in medicine. The blood sera of cancer patients are enriched with heterogeneous secretory lipid bound extracellular vesicles (EVs), which present a complex repertoire of information and biomarkers, representing their cell of origin, that are being currently studied in the field of liquid biopsy and cancer screening. Vibrational spectroscopies provide non-invasive approaches for the assessment of structural and biophysical properties in complex biological samples. In this study, multiple Raman spectroscopy measurements were performed on the EVs extracted from the blood sera of 9 patients consisting of four different cancer subtypes (colorectal cancer, hepatocellular carcinoma, breast cancer and pancreatic cancer) and five healthy patients (controls). FTIR(Fourier Transform Infrared) spectroscopy measurements were performed as a complementary approach to Raman analysis, on two of the four cancer subtypes. The AdaBoost Random Forest Classifier, Decision Trees, and Support Vector Machines (SVM) distinguished the baseline corrected Raman spectra of cancer EVs from those of healthy controls (18 spectra) with a classification accuracy of greater than 90% when reduced to a spectral frequency range of 1800 to 1940 inverse cm, and subjected to a 0.5 training/testing split. FTIR classification accuracy on 14 spectra showed an 80% classification accuracy. Our findings demonstrate that basic machine learning algorithms are powerful tools to distinguish the complex vibrational spectra of cancer patient EVs from those of healthy patients. These experimental methods hold promise as valid and efficient liquid biopsy for machine intelligence-assisted early cancer screening.